Mark Purcell
Stock Analyst at Morgan Stanley
(0)
# 4289
Out of 5,270 analysts
5
Total ratings
50.00%
Success rate
-10.13%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Novartis | Initiates Coverage On: Equal-Weight | 114 | 110.72 | 2.96% | 1 | Jan 23, 2024 | |
Sanofi | Initiates Coverage On: Equal-Weight | 55 | 56.55 | -2.74% | 1 | Jan 23, 2024 | |
GSK | Initiates Coverage On: Equal-Weight | 44 | 37.94 | 15.97% | 1 | Jan 23, 2024 | |
AstraZeneca | Initiates Coverage On: Overweight | 85 | 76.08 | 11.72% | 1 | Jan 23, 2024 | |
Novo Nordisk | Initiates Coverage On: Overweight | 120 | 89.48 | 34.11% | 1 | Jan 23, 2024 |